Tuesday, 16th May
2nd Australian Cancer and Metabolism Meeting 2017
Days
Monday, 15th May
Tuesday, 16th May
Wednesday, 17th May
Search
Speakers
Registration
8:00AM - 6:00PM
Tuesday, 16th May
Level 7 Foyer
Session 1: Immuno-metabolism & cancer
8:30AM - 10:30AM
Tuesday, 16th May
Theatre B
Chair: Professor Tony Tiganis
T-cell-receptor-dependent molecular regulation of inhibitory receptor expression and metabolic impairments of exhausted T cells
-
Axel Kallies
Functional and Metabolic Characteristics of CD8+ T cells in Ageing
-
Nicole La Gruta
B cell lymphoma induces metabolic stress and functional defects in Natural Killer cells
-
Stephen Mattarollo
Obesity prolongs survival in a murine model of myelodysplastic syndrome
-
Helene L Kammoun
NLRP1 exacerbates colitis-associated cancer through IL-18, with effects on butyrate producing Clostridiales.
-
Seth Masters
Morning Tea
10:30AM - 11:00AM
Tuesday, 16th May
Level 7 Foyer
Session 2: Metabolic Disease, Lifestyle Interventions & Cancer
11:00AM - 1:00PM
Tuesday, 16th May
Theatre B
Chair: Lisa Butler
Dynamic ‘omics reveals kinase signalling primes cells for glucose metabolism
-
James R Krycer
Role of Androgens and Androgen Targeted Therapies in Prostate Tumour Cell Metabolism
-
Colleen Nelson
Metabolic reprogramming associated with epithelial-mesenchymal transition in pancreatic cancer
-
Nigel Turner
Metabolic Characterization of Pancreatic Cancer-Derived Stem-Like Cells
-
Alice Domenichini
Metabolic reprogramming of neuronal dedifferentiation
-
Louise Cheng
Lunch
1:00PM - 2:00PM
Tuesday, 16th May
Level 7 Foyer
Session 3: Novel Metabolic Pathways and Signalling in Cancer I
2:00PM - 4:00PM
Tuesday, 16th May
Theatre B
Chair: Renea Taylor
The Hippo pathway’s sweet tooth: Yap reprograms glucose metabolism to fuel tissue growth.
-
Andrew Cox
Activation of the KEAP1-NRF2 pathway drives lung adenocarcinoma with an altered metabolism
-
Sarah A Best
Fatty acid metabolism in cancer.
-
Andrew Hoy
Enhanced lipid uptake: A novel metabolic target to fight the adaptive response to androgen-targeted therapies in prostate cancer
-
Kaylyn Tousignant
Coordinated translational and metabolic reprograming underpins synergistic effects of kinase inhibitors and biguanides
-
Ivan Topisirovic
Afternoon Tea
4:00PM - 4:30PM
Tuesday, 16th May
Level 7 Foyer
Plenary Lecture
4:30PM - 5:30PM
Tuesday, 16th May
Theatre B
Chair: Matthew Watt
Sponsored by:
Understanding metabolic phenotypes in human cancer
-
Ralph Deberardinis
Social Function
5:30PM - 7:30PM
Tuesday, 16th May
Level 7 Foyer
← Monday
Wednesday →